Influenza Vaccine (Senior)

Annual influenza vaccination is critical for adults ≥65 years who are at highest risk of flu-related complications including pneumonia, hospitalisation, and death. High-dose or adjuvanted formulations offer better protection in older adults.

The Influenza Vaccine (Senior) is recommended for 65 years and above; annually before flu season. It falls under the Senior / 60+ vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Influenza Vaccine (Senior) has an efficacy of 40–60%. This means it provides significant protection against Influenza (Seasonal Flu) and Flu-related Pneumonia. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Soreness at injection site; mild fever; myalgia; headache. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Influenza Vaccine (Senior) should be avoided by: Severe egg allergy; Guillain–Barré syndrome within 6 weeks of prior influenza vaccine. Always inform your healthcare provider of your full medical history before vaccination.

The Influenza Vaccine (Senior) typically costs ₹400 – ₹1,200 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.